{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:13:12Z","timestamp":1785683592056,"version":"3.56.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jaad.2022.07.063","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:17:55Z","timestamp":1661807875000},"page":"983-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["An update on Epstein-Barr virus\u2013and human T-lymphotropic virus type-1\u2013induced cutaneous manifestations. CME Part II"],"prefix":"10.1016","volume":"88","author":[{"given":"Alejandro A.","family":"Gru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar P.","family":"Sangueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Bravo","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martin","family":"Sangueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2022.07.063_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2022.07.063_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5581\/1516-8484.20110103","article-title":"Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant","volume":"33","author":"Gequelin","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.jaad.2022.07.063_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2014.07.034","article-title":"Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders","volume":"72","author":"Hall","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/ijd.14887","article-title":"Dermatological manifestations of Epstein-Barr virus systemic infection: a case report and literature review","volume":"59","author":"Ciccarese","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib5","first-page":"1458","article-title":"[The role Epstein-Barr virus played in the outcome of skin diseases]","volume":"101","author":"Lu","year":"2021","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jaad.2022.07.063_bib6","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-605-2020","article-title":"Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection","volume":"54","author":"Rosadas","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jaad.2022.07.063_bib7","article-title":"HTLV-1 and Co-infections","volume":"9","author":"Rosadas","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaad.2022.07.063_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/archdischild-2016-311526","article-title":"How to use \u2026 the Monospot and other heterophile antibody tests","volume":"102","author":"Marshall-Andon","year":"2017","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.jaad.2022.07.063_bib9","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaad.2022.07.063_bib10","first-page":"799","article-title":"Clinical inquiries. What test is the best for diagnosing infectious mononucleosis?","volume":"55","author":"Bell","year":"2006","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jaad.2022.07.063_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12875-019-0954-3","article-title":"Epstein-Barr virus and its association with disease - a review of relevance to general practice","volume":"20","author":"Fugl","year":"2019","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jaad.2022.07.063_bib12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1590\/abd1806-4841.20187021","article-title":"Epstein-Barr virus and skin","volume":"93","author":"Sangueza-Acosta","year":"2018","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1365-4632.2012.05855.x","article-title":"Epstein-Barr virus and skin manifestations in childhood","volume":"52","author":"Di Lernia","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0733-8635(01)00014-6","article-title":"Cutaneous manifestations of Epstein-Barr virus infection","volume":"20","author":"Ikediobi","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2022.07.063_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00128071-200809050-00003","article-title":"Mucocutaneous manifestations of Epstein-Barr virus infection","volume":"9","author":"Mendoza","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3315\/jdcr.2009.1035","article-title":"Erythema multiforme-like lesions in the course of infectious mononucleosis","volume":"3","author":"Zawar","year":"2009","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.jaad.2022.07.063_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaad.2016.08.034","article-title":"Viral exanthems: an update on laboratory testing of the adult patient","volume":"76","author":"Korman","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0022-3476(54)80144-2","article-title":"Periorbital edema as the initial sign of infectious mononucleosis","volume":"45","author":"Bass","year":"1954","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2022.07.063_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0002-9343(52)90154-X","article-title":"Infectious mononucleosis","volume":"13","author":"Hoagland","year":"1952","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2022.07.063_bib20","first-page":"177","article-title":"[Infectious mononucleosis and ampicillin]","volume":"14","author":"Cabo","year":"1986","journal-title":"Med Cutan Ibero Lat Am"},{"key":"10.1016\/j.jaad.2022.07.063_bib21","first-page":"207","article-title":"[Skin rash enhanced by ampicillin in a patient with infectious mononucleosis]","volume":"102","author":"Ito","year":"2005","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.jaad.2022.07.063_bib22","first-page":"e136","article-title":"[Aminopenicillin-induced exanthematous eruption in a patient with infectious mononucleosis]","volume":"42","author":"Santos-Alarcon","year":"2016","journal-title":"Semergen"},{"key":"10.1016\/j.jaad.2022.07.063_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1060028016669525","article-title":"Antibiotic-induced rash in patients with infectious mononucleosis","volume":"51","author":"Thompson","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2022.07.063_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMicm2104358","article-title":"Amoxicillin rash in infectious mononucleosis","volume":"385","author":"Mergoum","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2022.07.063_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jiac.2019.01.012","article-title":"Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus: a single-center case-control study in Japan","volume":"25","author":"Ishii","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jaad.2022.07.063_bib26","first-page":"1799","article-title":"[Common causes of infectious mononucleosis]","volume":"14","author":"Dumoulin","year":"2018","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.jaad.2022.07.063_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0212-6567(00)78505-2","article-title":"[\"Mononucleosis-like\" caused by carbamazepine]","volume":"25","author":"Navarro Fontanellas","year":"2000","journal-title":"Aten Primaria"},{"key":"10.1016\/j.jaad.2022.07.063_bib28","first-page":"202","article-title":"Mononucleosis and hepatic failure associated with diphenylhydantoin treatment in an infant","volume":"90","author":"Ni","year":"1991","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jaad.2022.07.063_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/03009742.2020.1747533","article-title":"Sulfasalazine-induced mononucleosis-like-illness and haemolysis","volume":"50","author":"Sahm","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib30","first-page":"372","article-title":"Common questions about infectious mononucleosis","volume":"91","author":"Womack","year":"2015","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2022.07.063_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JSM.0000000000000330","article-title":"Exercise and the athlete with infectious mononucleosis","volume":"27","author":"Shephard","year":"2017","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.jaad.2022.07.063_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jmv.24618","article-title":"Splenic infarction associated with acute infectious mononucleosis due to Epstein-Barr virus infection","volume":"89","author":"Heo","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaad.2022.07.063_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.injury.2015.10.071","article-title":"Splenic rupture in infectious mononucleosis: a systematic review of published case reports","volume":"47","author":"Bartlett","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.jaad.2022.07.063_bib34","first-page":"475","article-title":"The biology and clinical utility of EBV monitoring in blood","volume":"391","author":"Kanakry","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaad.2022.07.063_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41467-017-00257-5","article-title":"Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections","volume":"8","author":"Tian","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaad.2022.07.063_bib36","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI32377","article-title":"HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection","volume":"117","author":"McAulay","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2022.07.063_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1346-8138.1993.tb01299.x","article-title":"Atypical exanthema in a patient with infectious mononucleosis","volume":"20","author":"Kato","year":"1993","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-4362.2000.00890.x","article-title":"Pityriasis lichenoides-like exanthem and primary infection by Epstein-Barr virus","volume":"39","author":"Almagro","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.dad.0000164604.56650.26","article-title":"Adverse antibiotic-induced eruptions associated with epstein barr virus infection and showing Kikuchi-Fujimoto disease-like histology","volume":"28","author":"Carlson","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2022.07.063_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3346\/jkms.2010.25.2.321","article-title":"A case of hypersensitivity to mosquito bite associated with Epstein-barr viral infection and natural killer cell lymphocytosis","volume":"25","author":"Roh","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaad.2022.07.063_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archderm.1990.01670270094016","article-title":"Severe hypersensitivity to mosquito bites associated with natural\u00a0killer cell lymphocytosis","volume":"126","author":"Tokura","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib42","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jaad.2022.07.063_bib43","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2022.07.063_bib44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2022.07.063_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1349-7006.1997.tb00305.x","article-title":"Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells","volume":"88","author":"Ishihara","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.jaad.2022.07.063_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.0022-202X.2005.23915.x","article-title":"Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites","volume":"125","author":"Asada","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2006.11.002","article-title":"Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis","volume":"45","author":"Asada","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2022.07.063_bib48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/10428194.2019.1699080","article-title":"Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting","volume":"61","author":"Cohen","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2022.07.063_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.13411","article-title":"Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites","volume":"172","author":"Miyake","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib50","first-page":"503","article-title":"Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders","volume":"15","author":"Nitta","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.1999.00836.x","article-title":"Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line","volume":"115","author":"Tsuge","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2022.07.063_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1067\/mjd.2001.114751","article-title":"Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia\/lymphoma","volume":"45","author":"Tokura","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.jaad.2022.07.063_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4132\/KoreanJPathol.2013.47.2.137","article-title":"EBV-positive T\/NK-cell lymphoproliferative disease of childhood","volume":"47","author":"Hong","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.jaad.2022.07.063_bib55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/598645","article-title":"A case of severe chronic active infection with Epstein-Barr virus: immunologic deficiencies associated with a lytic virus strain","volume":"29","author":"Schwarzmann","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1086\/588790","article-title":"Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients","volume":"47","author":"Sonke","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jaad.2022.07.063_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2022.07.063_bib59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2022.07.063_bib60","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","article-title":"A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features","volume":"103","author":"Kawamoto","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2022.07.063_bib61","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","article-title":"Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification","volume":"4","author":"Yonese","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaad.2022.07.063_bib62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jaad.2022.07.063_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pathol.2019.09.011","article-title":"Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach","volume":"52","author":"Hue","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.jaad.2022.07.063_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaad.2022.07.063_bib66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib67","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF01973166","article-title":"\u00dcber eine eigenartige Geschw\u00fcrsform des weiblichen Genitales (ulcus vulvae acutum)","volume":"114","author":"Lipsch\u00fctz","year":"1913","journal-title":"Arch Dermatol Syph (Berlin)"},{"key":"10.1016\/j.jaad.2022.07.063_bib68","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM198410113111507","article-title":"Recovery of Epstein-Barr virus from genital ulcers","volume":"311","author":"Portnoy","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2022.07.063_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejogrb.2015.07.016","article-title":"Lipschutz ulcers: should we rethink this? An analysis of 33 cases","volume":"198","author":"Vieira-Baptista","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaad.2022.07.063_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/0956462414541241","article-title":"Genital ulcers: it is not always simplex","volume":"26","author":"Haidari","year":"2015","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2022.07.063_bib71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpag.2022.01.006","article-title":"Adolescents with vulvar ulcers: COVID-19 disease, COVID-19 vaccines, and the value of case reports","volume":"35","author":"Huppert","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jaad.2022.07.063_bib72","first-page":"297","article-title":"Lipschutz genital ulceration: a rare manifestation of paratyphoid fever","volume":"13","author":"Pelletier","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib73","first-page":"81","article-title":"[Lyme disease]","volume":"24","author":"Belaich","year":"1995","journal-title":"Presse Med"},{"key":"10.1016\/j.jaad.2022.07.063_bib74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1529-8019.2010.01356.x","article-title":"Lipschutz ulcers: evaluation and management of acute genital ulcers in women","volume":"23","author":"Huppert","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2022.07.063_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpag.2006.02.006","article-title":"Vulvar ulcers in young females: a manifestation of aphthosis","volume":"19","author":"Huppert","year":"2006","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jaad.2022.07.063_bib76","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11908-009-0065-8","article-title":"Genitourinary manifestations of epstein-barr virus infections","volume":"11","author":"Leigh","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jaad.2022.07.063_bib77","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2022.07.063_bib78","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12519-019-00269-9","article-title":"Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition","volume":"15","author":"Leung","year":"2019","journal-title":"World J Pediatr"},{"key":"10.1016\/j.jaad.2022.07.063_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1525-1470.1997.tb00955.x","article-title":"Gianotti-Crosti syndrome associated with Epstein-Barr virus infection","volume":"14","author":"Hofmann","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib80","first-page":"106","article-title":"Gianotti-Crosti syndrome associated with Ebstein-Barr virus and parvovirus B-19 coinfection in a male adult: case report and review of the literature","volume":"151","author":"Stojkovic-Filipovic","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2022.07.063_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2133.1986.tb06219.x","article-title":"Gianotti-Crosti syndrome: a study of 26 cases","volume":"115","author":"Taieb","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib82","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2133.1966.tb12181.x","article-title":"A pattern of eczema in Jamaica","volume":"78","author":"Sweet","year":"1966","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib83","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.134.4.439","article-title":"Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children","volume":"134","author":"La Grenade","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib84","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-4632.2009.04008.x","article-title":"Human T-cell lymphotropic virus type 1 infective dermatitis emerging in adulthood","volume":"48","author":"Maragno","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib85","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","article-title":"Inflammatory manifestations of HTLV-1 and their therapeutic options","volume":"10","author":"Martin","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaad.2022.07.063_bib86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.semdp.2019.04.002","article-title":"Infective dermatitis: a purely cutaneous manifestation of HTLV-1 infection","volume":"37","author":"Bravo","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.jaad.2022.07.063_bib87","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib88","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/cid\/cis273","article-title":"Infective dermatitis associated with human T-cell lymphotropic virus type 1: evaluation of 42 cases observed in Bahia, Brazil","volume":"54","author":"de Oliveira Mde","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S0100-879X2009005000008","article-title":"High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy\/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1","volume":"42","author":"Primo","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jaad.2022.07.063_bib90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/432058","article-title":"Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis in childhood and adolescence","volume":"41","author":"Primo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008241","article-title":"Clinicopathological aspects and proviral load of adulthood infective dermatitis associated with HTLV-1: comparison between juvenile and adulthood forms","volume":"14","author":"Souza","year":"2020","journal-title":"Plos Negl Trop Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib92","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/524695","article-title":"Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia\/lymphoma","volume":"46","author":"Farre","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib93","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0140-6736(91)92413-V","article-title":"Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years","volume":"338","author":"Hanchard","year":"1991","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaad.2022.07.063_bib94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/DAD.0000000000002044","article-title":"Progression of infective dermatitis associated with HTLV-1 to adult T-cell leukemia\/lymphoma-case report and literature review","volume":"44","author":"Rosa","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2022.07.063_bib95","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-4632.2010.04568.x","article-title":"Cutaneous manifestations associated with HTLV-1 infection","volume":"49","author":"Bittencourt","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib96","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1086\/430064","article-title":"Infective dermatitis associated with the human T cell lymphotropic virus type I in Salvador, Bahia, Brazil","volume":"40","author":"Oliveira Mde","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib97","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/pde.13702","article-title":"Infective dermatitis associated with HTLV-1 infection in a girl from Trinidad: case report and review of literature","volume":"36","author":"Weiler","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib98","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-4632.2011.04882.x","article-title":"Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications","volume":"50","author":"Amano","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib99","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2015.01.003","article-title":"HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes","volume":"77","author":"Torres-Cabala","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2022.07.063_bib100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood-2011-05-357459","article-title":"HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines","volume":"119","author":"Sugata","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2022.07.063_bib101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3960\/jslrt.18032","article-title":"Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016","volume":"59","author":"Kawano","year":"2019","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.jaad.2022.07.063_bib102","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.6206569","article-title":"Functional properties of antigen-specific T cells infected by human T-cell leukemia-lymphoma virus (HTLV-I)","volume":"225","author":"Mitsuya","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jaad.2022.07.063_bib103","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/ijd.12170","article-title":"Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I)","volume":"53","author":"Dantas","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib104","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4269\/ajtmh.2003.68.562","article-title":"Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1","volume":"68","author":"Goncalves","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2022.07.063_bib105","doi-asserted-by":"crossref","first-page":"e2546","DOI":"10.1371\/journal.pntd.0002546","article-title":"High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status","volume":"7","author":"Okajima","year":"2013","journal-title":"Plos Negl Trop Dis"},{"key":"10.1016\/j.jaad.2022.07.063_bib106","first-page":"273","article-title":"Cutaneous manifestations in HTLV-I positive blood donors","volume":"16","author":"Yazdanpanah","year":"2013","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.jaad.2022.07.063_bib107","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4269\/ajtmh.2005.72.855","article-title":"Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection","volume":"72","author":"Blas","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2022.07.063_bib108","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1365-4632.2008.03707.x","article-title":"Scabies superimposed on skin lesions of adult T-cell leukemia\/lymphoma: case report and literature review","volume":"47","author":"Kabashima","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2022.07.063_bib109","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/00002030-200206140-00015","article-title":"Severe and Norwegian scabies are strongly associated with retroviral (HIV-1\/HTLV-1) infection in Bahia, Brazil","volume":"16","author":"Brites","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2022.07.063_bib110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1346-8138.12328","article-title":"Skin manifestations of adult T-cell leukemia\/lymphoma: clinical, cytological and immunological features","volume":"41","author":"Tokura","year":"2014","journal-title":"J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222026093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222026093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:26:17Z","timestamp":1759274777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222026093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0190962222026093"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.07.063","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on Epstein-Barr virus\u2013and human T-lymphotropic virus type-1\u2013induced cutaneous manifestations. CME Part II","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.07.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.11.068","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}